QUIREDEX: Revlimid (Lenalidomide) and Dexamethasone (ReDex) Treatment Versus Observation in Patients With Smoldering Multiple Myeloma With High Risk of Progression (QUIREDEX)
Clinical Trial ID NCT00480363
PubWeight™ 12.88‹?›
🔗 Visit the ClinicalTrials.gov page for NCT00480363
Top papers
Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
Next 100